Är Medtronic utdelningen säker?
Medtronic har höjt utdelningen i 47 år.
Inom de senaste 10 åren har Medtronic ökat denna med årligen 5,749 % ökad.
På 5-årssikt ökade utdelningen med −0,285 %.
Analytikerna räknar med en Utdelningsökning på 1,142% för det löpande räkenskapsåret.
Medtronic Aktienanalyse
Vad gör Medtronic?
Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment.
Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market.
Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957.
In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders..
In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more.
In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed.
Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions.
In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems.
Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide.
Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic är ett av de mest populära företagen på Eulerpool.com.Aktiesparprogram erbjuder en attraktiv möjlighet för investerare att bygga upp ett långsiktigt kapital. En av huvudfördelarna är den så kallade kostnadsgenomsnittseffekten: Genom att regelbundet investera en fast summa i aktier eller aktiefonder, köper man automatiskt fler andelar när priserna är låga, och färre när de är höga. Detta kan leda till ett mer fördelaktigt genomsnittspris per andel över tid. Dessutom möjliggör aktiesparprogram även för småsparare att få tillgång till dyra aktier, eftersom de kan delta med små summor. Den regelbundna investeringen främjar också en disciplinerad investeringsstrategi och hjälper till att undvika emotionella beslut, som impulsivt köpande eller säljande. Utöver detta, drar investerare nytta av den potentiella värdetillväxten i aktierna såväl som från utdelningar som kan återinvesteras, vilket förstärker ränta-på-ränta-effekten och således tillväxten av det investerade kapitalet.
Aktien Medtronic kan sparas regelbundet hos följande leverantörer: Scalable Capital och Consorsbank